McIlrath & Eck LLC purchased a new stake in shares of Allstate Corp (NYSE:ALL) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 244 shares of the insurance provider’s stock, valued at approximately $27,000.

Other institutional investors have also added to or reduced their stakes in the company. South Texas Money Management Ltd. purchased a new stake in shares of Allstate in the second quarter valued at $209,000. DNB Asset Management AS increased its stake in Allstate by 18.4% in the 2nd quarter. DNB Asset Management AS now owns 119,332 shares of the insurance provider’s stock worth $12,135,000 after buying an additional 18,568 shares during the period. WINTON GROUP Ltd increased its stake in Allstate by 7,884.9% in the 2nd quarter. WINTON GROUP Ltd now owns 210,483 shares of the insurance provider’s stock worth $21,404,000 after buying an additional 207,847 shares during the period. Carroll Financial Associates Inc. increased its stake in Allstate by 6.4% in the 2nd quarter. Carroll Financial Associates Inc. now owns 2,508 shares of the insurance provider’s stock worth $255,000 after buying an additional 150 shares during the period. Finally, Retirement Systems of Alabama increased its stake in Allstate by 0.5% in the 2nd quarter. Retirement Systems of Alabama now owns 155,342 shares of the insurance provider’s stock worth $15,797,000 after buying an additional 766 shares during the period. 77.23% of the stock is currently owned by institutional investors.

Allstate stock traded up $0.47 during midday trading on Friday, hitting $108.19. 1,363,870 shares of the company’s stock were exchanged, compared to its average volume of 1,788,228. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.30 and a current ratio of 0.30. Allstate Corp has a 12 month low of $77.00 and a 12 month high of $109.55. The firm has a 50-day moving average of $107.47 and a two-hundred day moving average of $102.76. The company has a market cap of $34.29 billion, a PE ratio of 13.41, a P/E/G ratio of 1.27 and a beta of 0.81.

Allstate (NYSE:ALL) last issued its earnings results on Tuesday, October 29th. The insurance provider reported $2.84 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.52 by $0.32. Allstate had a net margin of 6.57% and a return on equity of 13.83%. The company had revenue of $10.87 billion for the quarter, compared to analysts’ expectations of $9.07 billion. During the same period in the prior year, the business earned $1.93 EPS. As a group, equities analysts expect that Allstate Corp will post 9.97 earnings per share for the current year.

In other Allstate news, EVP Susan L. Lees sold 27,650 shares of the stock in a transaction dated Monday, September 23rd. The shares were sold at an average price of $108.30, for a total transaction of $2,994,495.00. Following the transaction, the executive vice president now directly owns 53,165 shares in the company, valued at approximately $5,757,769.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Several research analysts recently commented on ALL shares. Buckingham Research raised their price target on shares of Allstate from $100.00 to $104.00 and gave the stock a “neutral” rating in a research note on Thursday, September 12th. UBS Group raised their price target on shares of Allstate from $110.00 to $112.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. Wells Fargo & Co raised their price target on shares of Allstate from $103.00 to $105.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Raymond James raised their price target on shares of Allstate from $115.00 to $125.00 and gave the stock a “strong-buy” rating in a research note on Thursday, August 1st. Finally, Evercore ISI started coverage on shares of Allstate in a research note on Thursday, October 17th. They issued an “in-line” rating and a $117.00 price target on the stock. Two analysts have rated the stock with a sell rating, eight have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Allstate currently has a consensus rating of “Hold” and a consensus price target of $110.17.

Allstate Company Profile

The Allstate Corporation, through its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection, Service Businesses, Allstate Life, and Allstate Benefits segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal lines products, such as renter, condominium, landlord, boat, umbrella, and manufactured home insurance; and commercial lines products under the Allstate, Esurance, and Encompass brand names.

Read More: What does relative strength index mean?

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allstate Corp (NYSE:ALL).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.